Introduction
Esthesioneuroblastoma is an uncommon malignant neoplasm that arises from the olfactory neuroepithelium 1 and is typically located in the upper nasal cavity and cribriform plate. 2 In this article we report a case of esthesioneuroblastoma presenting concomitantly with a growth-hormone (GH)-secreting pituitary macroadenoma. The combined open and endoscopic management of this patient is described, and a review of the literature presented.
Case Report
The patient is a 52-year-old woman who presented with a 9-month history of recurrent sinusitis refractory to a repeated course of antibiotics. She was seen by an outside ear nose and throat surgeon who operated on her for suspected nasal polyps. A partial debulking of an intranasal lesion disclosed a low-grade esthesioneuroblastoma. She complained of right orbital pain postoperatively and was
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Abstract
Background Esthesioneuroblastoma is an uncommon malignant neoplasm that arises from the olfactory neuroepithelium. In this article we report a case of esthesioneuroblastoma presenting concomitantly with a growth-hormone (GH)-secreting pituitary macroadenoma.
Results A 52 year old woman underwent surgery for suspected nasal polyps. Intralesional debulking of an intranasal tumor disclosed a low-grade esthesioneuroblastoma. Magnetic resonance imaging (MRI) demonstrated a large nasal and intracranial tumor, in addition to a separate sellar and suprasellar tumor. The patient was frankly acromegalic. She underwent a first-stage gross total resection of the esthesioneuroblastoma via a combined extended subfrontal and extended endonasal approach, followed by focused radiation therapy. She then returned for endoscopic removal of the GH-secreting pituitary macroadenoma.
Conclusion
The combined open and endoscopic management of this patient is described and a review of the literature presented. To our knowledge this is the first case of synchronous esthesioneuroblastoma and macroadenoma, in this case GH secreting, described in the literature. also treated for a postoperative sinusitis. In retrospect, she admitted to a 4-month history of anosmia, although she denied any alteration of taste. Neurosurgical clinical evaluation revealed frank acromegalic features. Visual acuity was 20/30-1 in both eyes with a very mild bitemporal hemianopia. Her eye movements were full and facial sensation was normal. Subsequent computed tomography and magnetic resonance imaging (MRI) of the brain and sinuses demonstrated an enhancing mass along the anterior skull base with extension through the right cribriform plate, with a lobular component displacing the right gyrus rectus, along the right medial orbital wall and into the nasal cavity. Also seen was a large sellar and suprasellar unrelated macroadenoma (►Fig. 1). A preoperative cervical MRI was negative for metastatic disease.
Her preoperative insulinlike growth factor (IGF)-1 level was 154.00 nmol/L (normal: 7.60-25.20 nmol/L), and prolactin was mildly elevated at 36.2 µg/L (normal: 3.9-29.5 µg/L). In light of the tumor size, the right lamina papyracea destruction, and significant intradural involvement, the tumor stage was classified as T4N0M0 based on the Dulguerov TNM system 3 and Kadish stage C. 4 A recommendation of staged resection of the esthesioneuroblastoma followed by the pituitary macroadenoma was made. For the first stage, a combined open and endoscopic resection was proposed, to facilitate a true en bloc resection and to harvest a generous pericranial flap for repair. Following this, the patient would undergo stereotactic radiation to the tumor bed, and she would return electively for endoscopic resection of the pituitary macroadenoma. The first-stage operation was performed as follows. An extended subfrontal approach was completed first, consisting of a bicoronal incision, bifrontal craniotomy, and bilateral orbital osteotomy sparing the cribriform plate. The tumor was immediately identified violating the dura. A generous extracapsular dissection of the intradural portion of the tumor was completed as well as a wide dural incision around the tumor, including posteriorly at the posterior aspect of the planum sphenoidale. The endonasal endoscopic approach was then performed (►Fig. 2), consisting of a right middle turbinectomy, complete sphenoethmoidectomies, and a superior septectomy. The lamina papyracea component of tumor was resected with the aid of a handheld retractor protecting the periorbita from the orbitotomy above (►Video 1). The anterior and posterior ethmoidal arteries were cauterized and divided. The left side of the planum was drilled out as was the posterior planum, releasing the tumor as a single specimen. As such, an en bloc resection was completed without violation of the tumor. The dural defect was reconstructed with a free pericranial graft, and a second pedicled pericranial flap was mobilized over the dural closure prior to replacement of the orbital osteotomy and craniotomy flap. Postoperatively she developed symptomatic pneumocephalus that was thought to be secondary to lumbar drain placement. The pneumocephalus resolved with 100% oxygen and discontinuation of the lumbar drain. There were no other complications postoperatively, and the patient was discharged home on postoperative day 7. The rationale for staging was to avoid potential complications during the esthesioneuroblastoma resection, such as a separate cerebrospinal fluid (CSF) leak or hypopituitarism, and possibly delaying adjuvant radiation therapy. Following complete resection of the esthesioneuroblastoma and radiation therapy, the patient returned to electively manage the pituitary tumor.
Video 1
Combined open and endoscopic resection of esthesioneuroblastoma. Online content including video sequences viewable at: www.thieme-connect.com/products/ejournals/html/ 10.1055/s-0034-1372472.
Pathologic examination (►Fig. 3) revealed a small blue cell tumor arranged in lobules and with mild nuclear pleomorphism. Rosettes were infrequent. There was positive staining for chromogranin A and synaptophysin. Sustentacular cells were present and stained positive for S-100 protein. The specimen was consistent with a Hyams grade 2 esthesioneuroblastoma. 5 Postoperative MRI confirmed gross total resection of the esthesioneuroblastoma (►Fig. 1D-F). Postoperatively, the patient underwent fractionated intensity-modulated radiation therapy to the resection area. A total of 60 Gy over 30 fractions were administered, after which six cycles of carboplatin and paclitaxel were given. As a second stage, 8 months following the first surgery, the patient underwent a complete endoscopic transsphenoidal removal of the pituitary macroadenoma (►Fig. 4). There was a mild intraoperative CSF leak at the end of the resection, and a right nasoseptal flap was harvested in this case to repair the sella as well as autologous fascia lata. The pericranial repair from the craniofacial resection site was pristine. She was discharged home on postoperative day 2 without complications. Pathology for the pituitary tumor was consistent with a pituitary adenoma, with both prolactin and GH positivity (►Fig. 3D). By 2-week follow-up, there was marked improvement in her acromegalic features, the patient's facial complexion had improved and the finger breadth diminished (►Fig. 5).
Postoperatively, her IGF-1 level normalized, from 154.00 to 22.00 nmol/L, consistent with endocrinologic cure. 
Discussion
To our knowledge this is the first case of synchronous esthesioneuroblastoma and macroadenoma, in this case GH secreting, described in the literature. Esthesioneuroblastoma has been described as a secondary tumor occurring many years after treatment for pituitary neoplasms, immunosuppression therapy. 22 Very rarely esthesioneuroblastoma presents in association with ectopic adrenocorticotropic hormone secretion.
23
Patients with acromegaly have an increased risk of several neoplasms including colorectal and thyroid cancer and possibly breast, prostate, and hematologic malignancies. 24 Both GH and IGF-1 are known to promote cellular growth and proliferation, and they may also have mitogenic, proangiogenic, and antiapoptotic properties. 25, 26 Several authors have observed an association between high serum IGF-1 lateral extension over the orbital roof, extensive frontal sinus involvement, and invasion through the lamina papyracea into the intraorbital space all increase the level of difficulty of achieving a gross total resection via an endoscopic approach. 37 In our case, endoscopic visualization of the inferior cuts facilitated a true en bloc resection of the esthesioneuroblastoma, without the use of facial incisions or intralesional debulking. It is generally accepted that complete resection followed by adjuvant radiation therapy reduces the rate of local recurrence in patients with esthesioneuroblastoma 38 and improves disease-free survival. 39, 40 Chemotherapy remains a matter of debate in upfront treatment, with typical indications being high-grade, recurrent, metastatic, or unresectable tumors. 41 In some centers, neoadjuvant chemotherapy has been used with success prior to standard craniofacial resection
42,43

Conclusion
In this patient, complete resection of an esthesioneuroblastoma was achieved using a combined open craniofacial and endoscopic approach, followed by a complete endoscopic resection of a GH-secreting pituitary macroadenoma, resulting in endocrinologic cure. The relative indications and advantages of the expanded endonasal approach for anterior skull base malignancies are illustrated.
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